Should the deceased be listed as authors?


Journal

Journal of medical ethics
ISSN: 1473-4257
Titre abrégé: J Med Ethics
Pays: England
ID NLM: 7513619

Informations de publication

Date de publication:
05 2019
Historique:
received: 08 12 2018
revised: 28 01 2019
accepted: 04 02 2019
pubmed: 3 3 2019
medline: 11 8 2020
entrez: 3 3 2019
Statut: ppublish

Résumé

Sometimes participants in research collaboration die before the paper is accepted for publication. The question we raise in this paper is how authorship should be handled in such situations. First, the outcome of a literature survey is presented. Taking this as our starting point, we then go on to discuss authorship of the dead in relation to the requirements of the Vancouver rules. We argue that in principle the deceased can meet the requirements laid down in these authorship guidelines. However, to include a deceased researcher as author requires a strong justification. The more the person has been involved in the research and writing process before he or she passes away, the stronger the justification for inclusion.

Identifiants

pubmed: 30824494
pii: medethics-2018-105304
doi: 10.1136/medethics-2018-105304
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-338

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Gert Helgesson (G)

Stockholm Centre for Healthcare Ethics, Department of Learning, Informatics, Management, and Ethics, Karolinska Institutet, Stockholm, Sweden.

William Bülow (W)

Department of Philosophy, Stockholm University, Stockholm, Sweden.

Stefan Eriksson (S)

Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden.

Tove E Godskesen (TE)

Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden.
Department of Health Care Sciences, Ersta Sköndal Bräcke University College, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH